Aplasia cutis congenita with skull defect in a monozygotic twin after exposure to methimazole in utero

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 79, Issue 10, 2007, Pages 680-684

  Iwayama, Hideyuki ^a,b   Hosono, Haruki ^a   Yamamoto, Hikaru ^a   Oshiro, Makoto ^a   Ueda, Norishi ^b  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aplasia cutis congenita; Methimazole; Monozygotic twin; Skull defect

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; PETROLATUM; POVIDONE IODINE; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; THIAMAZOLE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BIRTH DEFECT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; EPITHELIZATION; FAMILY HISTORY; FEMALE; HUMAN; HYPERTHYROIDISM; INFANT; INHERITANCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOZYGOTIC TWINS; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SKIN APLASIA; SKIN INFECTION; SKULL DEFECT; WOUND DRESSING;

ANTI-BACTERIAL AGENTS; ANTITHYROID AGENTS; ECTODERMAL DYSPLASIA; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; HYPERTHYROIDISM; INFANT, NEWBORN; INFECTION; MALE; METHIMAZOLE; PEPTIDE FRAGMENTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; SKULL; TWINS, MONOZYGOTIC;

EID: 35348845738     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20395     Document Type: Article

References (34)

1. Demmel U. 1975. Clinical aspects of congenital skin defects. I. Congenital skin defects on the head of the newborn. Eur J Pediatr 121:21-50.
2. Evers MEJW, Steijlen PM, Hamel BCJ. 1995. Aplasia cutis congenita and associated disorders: an update. Clin Genet 47:295-301.
3. Ferraris S, Valenzise M, Lerone M, et al. 2003. Malformations following methimazole exposure in utero: an open issue. Birth Defects Res A Clin Mol Teratol 67:989-992.
4. Fonseca W, Alencar AJC, Pereira RMM, et al. 1993. Congenital malformation of the scalp and cranium after failed first trimester abortion attempt with misoprostol. Clin Dysmorphol 2:76-80.
5. Frieden IJ. 1986. Aplasia cutis congenita: a clinical review and proposal for classification. J Am Acad Dermatol 14:646-660.
6. Gorlin RJ, Cohen MM Jr, Hennekam RCM. 2001. Syndromes affecting the skin and mucosa. In: Syndromes of the Head and Neck. 4th ed. New York: Oxford University Press. p 494-498.
7. Hubert A, Bonneau D, Couet D, et al. 1994. Aplasia cutis congenita of the scalp in an infant exposed to valproic acid in utero. Acta Paediatr 83:789-790.
8. Izhar R, Ghani T. 2002. Aplasia cutis congenita and antithyroid drugs. J Pak Med Assoc 52:526-528.
9. Kalb RE, Grossman ME. 1986. The association of aplasia cutis congenita with therapy of maternal thyroid disease. Pediatr Dermatol 3:327-330.
10. Karg E, Bereg E, Gaspar L, et al. 2004. Aplasia cutis congenita after methimazole exposure in utero. Pediatr Dermatol 21:491-494.
11. Kodama F, Fukushima K, Umeda M. 1980. Chromosome aberrations induced by clinical medicines. J Toxicol Sci 5:141-150.
12. Martin-Denavit T, Edery P, Plauchu H, et al. 2000. Ectodermal abnormalities associated with methimazole intrauterine exposure. Am J Med Genet 94:338-340.
13. Martinez-Frias ML, Cereijo A, Rodriguez-Pinilla E, et al. 1992. Methimazole in animal feed and congenital aplasia cutis. Lancet 339:742-743.
14. Martinez-Lage JF, Almagro MJ, Hernandez FL, et al. 2002. Aplasia cutis congenita of the scalp. Childs Nerv Syst 18:634-637.
15. Mazue G, Bertolero F, Jacob C, et al. 1991. Preclinical and clinical studies with recombinant human basic fibroblast growth factor. Ann NY Acad Sci 638:329-340.
16. Milham S Jr, Elledge W. 1972. Maternal methimazole and congenital defects in children. Teratology 5:125-126.
17. Mortimer RH, Cannell GR, Addison RS, et al. 1997. Methimazole and propylthiouracil equally cross the perfused human placental lobule. J Clin Endocrinol Metab 82:3099-3102.
18. Mujtaba Q, Burrow GN. 1975. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole. Obstet Gynecol 46:282-286.
19. Nakamura S, Nishikawa T, Isaji M, et al. 2005. Aplasia cutis congenita and skull defects after exposure to methimazole in utero. Intern Med 44:1202-1203.
20. Nakanishi A, Hakamada A, Isoda K, et al. 2005. Atelocollagen sponge and recombinant basic fibroblast growth factor combination therapy for resistant wounds with deep cavities. J Dermatol 32:376-380.
21. Perlyn CA, Schmelzer R, Govier D, et al. 2005. Congenital scalp and calvarial deficiencies: principles for classification and surgical management. Plast Reconstr Surg 115:1129-1141.
22. Quirinia A, Viidik A. 1998. The effect of recombinant basic fibroblast growth factor (bFGF) in fibrin adhesive vehicle on the healing of ischaemic and normal incisional skin wounds. Scand J Plast Reconstr Surg Hand Surg 32:9-18.
23. Reitnauer PJ, Callanan NP, Farber RA, et al. 1997. Prenatal exposure to disulfiram implicated in the cause of malformations in discordant monozygotic twins. Teratology 56:358-362.
24. Restaino I, Kaplan BS, Kaplan P, et al. 1991. Renal dysgenesis in a monozygotic twin: association with in utero exposure to indomethacin. Am J Med Genet 39:252-257.
25. Santos de Oliveira R, Barros Juca CE, Lopes Lins-Neto A, et al. 2006. Aplasia cutis congenita of the scalp: is there a better treatment strategy? Childs Nerv Syst 22:1072-1079.
26. Schinzel AAGL, Smith DW, Miller JR. 1979. Monozygotic twinning and structural defects. J Pediatr 95:921-930.
27. Sharif S, Hay CRM, Clayton-Smith J. 2005. Aplasia cutis congenita and low molecular weight heparin. BJOG 112:256-258.
28. Shivakumar SK, Dwarakanath S, Swaroop G, et al. 2006. Aplasia cutis congenita of the scalp: therapeutic modalities. Neurol Ind 54:312-313.
29. Stanisstreet M, Herbert LC, Pharoah PO. 1990. Effects of thyroid antagonists on rat embryos cultured in vitro. Teratology 41:721-729.
30. Stevenson RE, DeLoache WR. 1998. Aplasia Cutis Congenita of the scalp. Proc Greenwood Genet Center 7:14-18.
31. Van Dijke CP, Heydendael RJ, De Kleine MJ. 1987. Methimazole, carbimazole, and congenital skin defects. Ann Intern Med 106:60-61.
32. Vogt T, Stolz W, Landthaler M. 1995. Aplasia cutis congenita after exposure to methimazole: a causal relationship? Br J Dermatol 133:994-996.
33. Yagupsky P, Reuveni H, Karplus M, et al. 1986. Aplasia cutis congenital in one of monozygotic twins. Pediatr Dermatol 3:403-405.
34. Yamanaka K, Inaba T, Nomura E, et al. 2005. Basic fibroblast growth factor treatment for skin ulcerations in scleroderma. Cutis 76:373-376.